重新审视子宫内膜癌腹腔细胞学阳性的预后意义
该回顾性多中心研究纳入1616例子宫内膜癌手术患者,分析腹腔细胞学(PC)阳性的预后价值。结果显示,PC阳性在所有分期和肿瘤类型中均为独立不良预后因素;早期PC阳性患者的生存曲线介于II期PC阴性与III期患者之间;在早期中危和高危组中PC阳性与更差的无进展生存相关,低危组则无关。
要点
- PC阳性是子宫内膜癌全分期和全肿瘤类型的独立不良预后因素。
- 早期PC阳性患者生存介于II期PC阴性与III期之间,或可考虑升级分期。
- 早期中危和高危组PC阳性与更差PFS相关,低危组无关。
核心结论
- 腹腔细胞学阳性是子宫内膜癌所有分期和肿瘤类型的独立预后因素。
- 早期PC阳性患者(除低危组外)可考虑升级分期并较PC阴性者更谨慎管理。
研究设计与样本
- 回顾性多中心研究,纳入四家医院 affiliated with the Jikei University School of Medicine 的子宫内膜癌手术患者。
- 1963例中1616例符合纳入标准,至少行子宫切除术且病理诊断为子宫内膜癌。
- 采用单因素和多因素分析,在全体队列及按手术分期、肿瘤类型和风险分类分层的亚组中评估PC预后意义。
主要发现
- 在所有子宫内膜癌病例分析及按手术分期和肿瘤类型分层的所有亚组分析中,PC阳性均为不良预后因素。
- 生存曲线比较中,早期PC阳性患者的无进展生存(PFS)和疾病特异性生存明确位于II期PC阴性患者与III期患者之间。
- 在早期子宫内膜癌按风险分类的亚组分析中,PC阳性与中危和高危组更差PFS相关,但与低危组无关。
临床怎么用
- 应将PC状态纳入子宫内膜癌预后评估,尤其关注早期中危和高危PC阳性患者。
- 对早期PC阳性(除低危组外)患者可考虑升级分期并加强管理。
局限性
- 回顾性研究设计可能引入选择偏倚和信息偏倚。
- 研究来自四家医院 affiliated with the Jikei University School of Medicine,外推性需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Whether abnormal peritoneal cytology (PC) is an independent prognostic factor in endometrial cancer (EC) remains controversial. This study aimed to re-think the prognostic significance of PC in not only all EC patients but also in various subgroups with similar clinicopathological and biological characteristics. METHODS: EC patients who underwent primary surgery of at least a hysterectomy and were pathologically diagnosed with EC in four hospitals affiliated with the Jikei University School of Medicine were retrospectively reviewed. The prognostic significance of PC was evaluated with univariate and multivariate analyses in the entire cohort and subgroups stratified by surgical stages (early/advanced stages), tumor types (types 1/2), and risk classifications (low/intermediate/high). RESULTS: Of 1963 EC cases, 1616 met the inclusion criteria. Positive PC was identified as an adverse prognostic factor in analyses of all EC cases and in all subgroup analyses stratified by surgical stages and tumor types. In survival curve comparisons, the progression-free survival (PFS) and disease-specific survival in early-stage patients with positive PC were clearly located between those of stage II patients with negative PC and stage III patients. In the subgroup analyses stratified by risk classification in early-stage EC, positive PC was related to poorer PFS in the intermediate- and high-risk groups but not in the low-risk group. CONCLUSION: PC status was an independent prognostic factor of EC in all stages and tumor types. Early PC-positive cases, except for the low-risk group, may be recommended for upstaging and should be carefully managed compared with PC-negative cases.
引用
- Takenaka M, Kamii M, Iida Y, et al. Re-thinking the prognostic significance of positive peritoneal cytology in endometrial cancer. Gynecol Oncol. 2021. PMID: 33551195. doi:10.1016/j.ygyno.2021.01.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。